J Korean Med Sci.  2004 Jun;19(3):333-340. 10.3346/jkms.2004.19.3.333.

Bacterial Growth in Amniotic Fluid Is Dependent on the Iron-Availability and the Activity of Bacterial Iron-Uptake System

Affiliations
  • 1Department of Pediatrics, Seonam University Medical School, Namwon, Korea.
  • 2Department of Pediatrics, Chosun University Medical School, Gwangju, Korea.
  • 3Department of Anatomy, Chosun University Medical School, Gwangju, Korea.
  • 4Department of Microbiology and Research Center for Resistant Cells, Chosun University Medical School, Gwangju, Korea. shsin@chosun.ac.kr

Abstract

In the present study, the relationship among iron-availability, antibacterial activity, role of meconium as an iron source and the activity of bacterial iron-uptake system (IUS) for bacterial growth in amniotic fluid (AF) were investigated. Staphylococcus aureus ATCC 6538 and its streptonigrin-resistant (SR) mutant with defective IUS were used as the test strains. The growth of S. aureus in AF was stimulated dosedependently by addition of meconium. Bacterial growth stimulated by meconium was re-inhibited dose-dependently by addition of iron-chelator, dipyridyl and apotransferrin. Iron concentration was correlated with the meconium content in AF (r(2)= 0.989, p=0.001). High-affinity IUS of S. aureus was expressed only in AF but not in AF with meconium. The growth of SR strain was more retarded than that of the parental strain in the iron-deficient brain heart infusion (ID-BHI), clear AF and AF containing apotransferrin. The retarded growth of both strains in the ID-BHI and AF was recovered by addition of holotransferrin, hemoglobin and FeCl3. Taken together, the antibacterial activity of AF is closely related with low iron-availability. Bacterial growth in AF considerably depends on the activity of bacterial IUS. Meconium acts as one of the exogenous iron-sources and thus can stimulate bacterial growth in AF.

Keyword

Amniotic Fluid; Staphylococcus aureus; Iron; Iron Chelating Agents

MeSH Terms

Amniotic Fluid/*microbiology
Antibiotics, Antineoplastic/pharmacology
Chelating Agents/pharmacology
Dose-Response Relationship, Drug
Female
Ferric Compounds/pharmacology
Human
Iron/*metabolism
Ligands
Meconium/metabolism
Mutation
Pregnancy
Pregnancy Trimester, Third
Protein Binding
Staphylococcus aureus/metabolism
Streptonigrin/pharmacology
Support, Non-U.S. Gov't
Time Factors

Figure

  • Fig. 1 Dose-dependent growth stimulation by meconium in amniotic fluid (AF). About 1×105 cfu/mL of the preconditioned S. aureus ATCC 6538 was inoculated into the iron-sufficient BHI (IS-BHI) and AF containing 1, 5 and 10 mg/mL of meconium, respectively, and cultured with vigorous shaking (200 rpm) at 37℃ for 12 hr. At the indicated intervals, bacterial growth was measured by optical density at 600 nm of wavelength. Experiments were carried out at least three times with similar results, and a representative one is shown.

  • Fig. 2 Dose-dependent growth inhibition by dipyridyl (A) and apotransferrin (AT; B) in meconium-stained AF (MSAF; 5 mg/mL of meconium). About 1×105 cfu/mL of the preconditioned S. aureus ATCC 6538 was inoculated into the MSAF containing 10, 100 and 1,000 µg/mL of dipyridyl, and the MSAF containing 0.1 and 0.3 mg/mL of apotransferrin, respectively, and cultured with vigorous shaking (200 rpm) at 37℃ for 12 hr. At the indicated intervals, bacterial growth was measured by optical density at 600 nm of wavelength. Experiments were carried out at least three times with similar results, and a representative one is shown.

  • Fig. 3 Correlation between iron concentration and meconium content in amniotic fluid (AF). Iron concentration was well correlated with meconium content in AF [Y=14.33X+9.0 (r2=0.989, p=0.001)].

  • Fig. 4 (A) Siderophore production in the amniotic fluid (AF) and meconium-stained AF (MSAF; 5 mg of meconium). The squared diameter (mm2) indicates the production of siderophore (mean±standard error) in the culture supernatants. Symbol (#) indicates the results showing statistically-significant difference (p<0.05) between the ID- and IS-BHI. (B) Expression of staphylococcal transferrin-binding protein (StbA; about 38 kDa) in AF and MSAF, and (C) iron-dependent expression of StbA in ID-BHI with various concentrations of FeCl3. About 1×105 cfu/mL of the preconditioned S. aureus ATCC 6538 was inoculated into the test media. Bacterial growth was shown in Fig. 1, 5. Cell wall proteins were isolated from the bacterial pellets after 24 hr-cultures. A 60 µg of cell wall proteins was electrophoresed and transferred to nitrocellulose membrane. StbA was probed with human transferrin-conjugated with horseradish peroxidase. Abbreviations: ID-BHI for iron-deficient BHI, IS-BHI for iron-sufficient BHI, AF for amniotic fluid and MSAF for meconium-stained amniotic fluid.

  • Fig. 5 Comparison of growth (A), siderophore production (B) and expression of transferrin-binding protein (StbA; C) between the parental strain (ATCC 6538) and its mutant (SR). About 1×105 cfu/mL of the preconditioned S. aureus ATCC 6538 was inoculated into the iron-deficient (ID) and the iron-sufficient (IS) BHI. Bacterial growth was measured by optical density at 600 nm of wavelength. The experiment was carried out at least three times with similar results, and a representative one was shown. The squared diameter (mm2) indicates the production of siderophore (mean±standard error) in the culture supernatants after 24 hr-cultures. Symbol (#) indicates the result showing statistically-significant difference (p<0.05) between the two strains. A 60 µg of cell wall proteins obtained from the bacterial pellets after 24 hr-culture was electrophoresed and transferred to nitrocellulose membrane. StbA was probed with human transferrin-conjugated with horseradish peroxidase.

  • Fig. 6 Growth according to the addition of various iron sources into the iron-deficient (ID) BHI. Two bacterial strains were used: S. aureus ATCC 6538 standard strain and streptonigrin-resistant (SR) strain. About 1×105 cfu/mL of the bacteria was inoculated into the ID-BHI (C) containing 0.5 mg/ mL of apotransferrin (A), 0.5 mg/mL of holotransferrin (B), 5 µM of FeCl3 (D) and 0.5 mg/mL of hemoglobin (E). Bacterial growth was measured by optical density (OD) at 600 nm of wavelength at the indicated intervals. Experiments were carried out at least three times with similar results, and a representative result was shown.

  • Fig. 7 Growth according to the addition of various iron sources into the amniotic fluid (AF). Two bacterial strains were used: S. aureus ATCC 6538 standard strain and streptonigrin-resistant (SR) strain. About 1×105 CFU/mL of the bacteria was inoculated into the AF (C) containing 0.5 mg/mL of apotransferrin (A), 0.5 mg/mL of holotransferrin (B), 5 µM of FeCl3 (D) and 0.5 mg/mL of hemoglobin (E). Bacterial growth was measured by optical density (OD) at 600 nm of wavelength at the indicated intervals. Experiments were carried out at least three times with similar results, and a representative result was shown.


Reference

1. Abbasi IA, Hemming VG, Eglinton GS, Johnson TR. Proliferation of group B streptococci in human amniotic fluid in vitro. Am J Obstet Gynecol. 1987. 156:95–99.
Article
2. Evans HE, Levy E, Glass L. Effect of amniotic fluid on bacterial growth. Obstet Gynecol. 1977. 49:35–37.
3. Galask RP, Snyder IS. Antimicrobial factors in amniotic fluid. Am J Obstet Gynecol. 1970. 106:59–65.
Article
4. Honkonen E, Näntö V, Hyörä H, Vuorinen K, Erkkola R. Trace elements and antibacterial activity in amniotic fluid. Biol Neonate. 1986. 50:21–26.
Article
5. Oka K, Hagio Y, Tetsuoh M, Kawano K, Hamada T, Kato T. The effect of transferrin and lysozyme on the antibacterial activity of amniotic fluid. Biol Res Pregnancy Perinatol. 1987. 8:1–6.
6. Schlievert P, Johnson W, Galask RP. Bacterial growth inhibition by amniotic fluid. VI. Evidence for a zinc-peptide antibacterial system. Am J Obstet Gynecol. 1976. 125:906–910.
7. Tran SH, Caughey AB, Musci TJ. Meconium-stained amniotic fluid is associated with puerperal infections. Am J Obstet Gynecol. 2003. 189:746–750.
Article
8. Edwards RK. Meconium-stained amniotic fluid and its association with obstetric infections. Prim Care Update OB/Gyns. 1998. 5:315–318.
Article
9. Romero R, Hanaoka S, Mazor M, Athanassiadis AP, Callahan R, Hsu YC, Avila C, Nores J, Jimenez C. Meconium-stained amniotic fluid: A risk factor for microbial invasion of the amniotic cavity. Am J Obstet Gynecol. 1991. 164:859–862.
Article
10. Hoskins IA, Hemming VG, Johnson TR, Winkel CA. Effects of alterations of zinc-to-phosphorus ratios and meconium content on Group B Streptococcus growth in human amniotic fluid in vitro. Am J Obstet Gynecol. 1987. 157:770–773.
Article
11. Clark P, Duff P. Inhibition of neutrophil oxidative burst and phagocytosis by meconium. Am J Obstet Gynecol. 1995. 173:1301–1305.
Article
12. Florman AL, Teubner D. Enhancement of bacterial growth in amniotic fluid by meconium. Brief clinical and laboratory observations. J Pediatr. 1969. 74:111–114.
13. Friel JK, Matthew JD, Andrews WL, Skinner CT. Trace elements in meconium from preterm and full-term infants. Biol Neonate. 1989. 55:214–217.
Article
14. Larsen B, Snyder IS, Galask RP. Transferrin concentration in human amniotic fluid. Am J Obstet Gynecol. 1973. 117:952–954.
Article
15. Auger P, Marquis G, Dallaire L, Joly J. Stunted growth Candida albicans in human amniotic fluid in vitro. J Lab Clin Med. 1980. 95:272–281.
16. Thadepalli H, Gangopadhyay PK, Maidman JE. Amniotic fluid analysis for antimicrobial factors. Int J Gynaecol Obstet. 1982. 20:65–72.
Article
17. Trivier D, Courcol RJ. Iron depletion and virulence in Staphylococcus aureus. FEMS Microbiol Lett. 1996. 141:117–127.
18. Lim Y, Shin SH, Lee SI, Kim IS, Rhee JH. Iron repressibility of siderophore and transferrin-binding protein in Staphylococcus aureus. FEMS Microbiol Lett. 1998. 163:19–24.
19. Taylor JM, Heinrichs DE. Transferrin binding in Staphylococcus aureus: involvement of a cell wall-anchored protein. Mol Microbiol. 2002. 43:1603–1614.
Article
20. Chung JH, Park MH, Kim JH, Lim Y, Shin SH. Growth and siderophore production of staphylococci in human peritoneal dialysate. J Korean Med Sci. 2003. 18:158–162.
Article
21. Leong SA, Neilands JB. Siderophore production by phytopathogenic microbial species. Arch Biochem Biophys. 1982. 218:351–359.
Article
22. Yeowell HN, White JR. Iron requirement in the bactericidal mechanism of streptonigrin. Antimicrob Agents Chemother. 1982. 22:961–968.
Article
23. Shin SH, Lim Y, Lee SE, Yang NW, Rhee JH. CAS agar diffusion assay for the measurement of siderophores in biological fluids. J Microbiol Methods. 2001. 44:89–95.
Article
24. Cheung AL, Fischetti VA. Variation in the expression of cell wall proteins of Staphylococcus aureus grown on solid and liquid media. Infect Immun. 1988. 56:1061–1065.
25. Weinberg ED, Weinberg GA. The role of iron in infection. Curr Opin Infect Dis. 1995. 8:164–169.
Article
26. Neilands JB. Siderophores: structure and function of microbial iron compounds. J Biol Chem. 1995. 270:26723–26726.
27. Simpson LM, Oliver JD. Ability of Vibrio vulnificus to obtain iron from transferrin and other iron-binding proteins. Curr Microbiol. 1987. 15:155–157.
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr